Ian Marks Email & Phone Number

New York, Ny, Us

New York, Ny, Us

Seattle, Wa, Us

Responsible for the development and execution of the global healthcare and life sciences strategy, driving innovative solutions while enhancing adoption of AWS products and services▪ Established new Industry Innovation Center (IIC) operating model as the 'innovation engine' for AWS' Healthcare and Life Sciences Industry Business Unit, aligning multi-disciplinary teams across geographies and functionalities for strategic initiatives.▪ Spearheaded the collection and synthesis of market signals from various stakeholders, translating these signals into coherent segment strategies that addressed customer needs and market viability. ▪ Led the creation of a solution portfolio strategy that solved end-to-end business problems for customers, enabling them to adopt AWS quickly and drive innovation. Successfully identified and evaluated potential solutions based on business case, risk, time to launch, and strategic importance.▪ Established a robust structural framework for the IIC that fostered cross-collaboration, individual ownership, and accountability, ensuring seamless execution of complex, multi-team projects.▪ Implemented an effective co-creation model with lighthouse customers, co-developing solutions to address cross-industry problems, accelerating time to market, increasing potential revenue, and strengthening customer relationships.

San Francisco, California, Us

Responsible for the development and execution of the global life sciences strategy to enable expansion into new sub-verticals to fuel growth in the Pharma and MedTech industries.▪ Accountable for delivering cross-cloud solution offerings to help drive digital transformation within the Salesforce Life Sciences customer base.▪ Defined the market positioning and client narrative for Pharma and MedTech through market insights, customer feedback and competitive signals.▪ Developed and executed on an integrated go to market plan for the Pharma and MedTech industry segments working with sales, marketing and product development leaders.▪ Executive sponsor for strategic client accounts to drive differentiated narrative for industry specific partnerships and alliances.▪ Provided key deal support to the global sales organization (Enterprise, Commercial & SMB) to exceed financial sales targets (+126% vs target).

Brentford, Middlesex, Gb

Created innovation strategy that expanded GSK Consumer Healthcare by leveraging broad external network across multiple sectors. Built a robust balanced pipeline of both incremental and breakthrough innovation opportunities. ▪ Built a new strategically focused External Innovation capability to optimize R&D spend and resource deployment with +40% of pipeline on-track to be externally sourced.▪ Drove development of new Rx to OTC Switch Center of Excellence to position GSK for long-term growth and built capabilities that enabled identification of over +$700M in pipeline opportunities. ▪ Established new Emerging Science group that drove +$500M in pipeline value and enabled a strategic shift in GSK’s where-to-play-areas due to an expanded focus of cross-category breakthrough platform technologies.▪ Improved holistic consumer experiences with +90% increase in product acceptability vs. competition via in-depth understanding of sensorial attributes across GSK categories and adoption of new sensory methodologies.▪ Expanded innovation pipeline to include +25% increase in identification of original healthcare solutions via strategic development of digital technology capabilities and infrastructure.▪ Developed strong social media presence with +20K followers and regularly publish thought-leadership content on wide range of innovation topics.

Basel, Baselstadt, Ch

Led identification of innovation opportunities that would enable expansion into new categories to fuel growth. Leveraged breakthrough science backed and consumer led insights to create innovation platforms. ▪ Built a cross-functional ideation team to support the identification, design and execution of innovative research concepts; resulting in the exploration of new therapeutic areas.▪ Drove significant Proof of Concept (PoC) study efficiency by creating a PoC Center of Excellence enabling research concepts to be validated in less than 1 year, and for less than $1M in spend.▪ Established, and chaired a cross-functional science forum to provide counsel to teams on science, innovation, strategy, and emerging challenges which resulted in 25% increase in quality of research proposals.▪ Developed capabilities and therapeutic area knowledge in the research department by initiating cross-divisional partnerships with Novartis Institute for Biomedical Research, Translational Sciences and Pharma.▪ Streamlined governance for research programs and maximized R&D output through a staged gate approach (fail early) to +50% reduction in study time and spend.

Basel, Baselstadt, Ch

Provided leadership for the operational conduct of global development programs and clinical trials resulting in standards and processes being implemented with a high level of compliance. ▪ Head of Project Management for the EM Development Franchise (40 FTEs) responsible for embedding excellence in program and risk management resulting in +90% of project milestones delivered on time. ▪ Led the development and implementation a comprehensive change strategy that included stakeholder assessment, communication strategy, rewards and recognition program, retention plan, and execution plan.▪ Successfully led a cross-franchise platform to drive planning and clinical operational excellence across development, enabling efficient coordination with key partner functions, such as Finance, HR, and Clinical.▪ Established, and chaired, the EM Franchise Operations Board, responsible for planning, allocation and management of internal and external resources ($90M budget). ▪ Core member of the Franchise Leadership Team (FLT) and provided resource allocation expertise, led tradeoff discussions and contributed to the franchise strategy.

Basel, Baselstadt, Ch

Drove cross-functional alignment and operational excellence, while developing strategy and portfolio management initiatives as a member of the Integrated Franchise Board.

Basel, Baselstadt, Ch

Led strategy for the international teams responsible for the development of Lucentis (wet AMD) and Rebamipide (Dry Eye). Overall accountability for innovation, strategy, operations, and all related development deliverables.

Basel, Baselstadt, Ch

Acted as liaison between the International Clinical Teams (ICTs) and the Novartis Country Pharma Organizations to facilitate clinical trial planning and execution in Dermatology and Infectious Diseases.

Basel, Baselstadt, Ch

Global Clinical Trial Leader directing all study related activities for registration and post-marketing studies.

Switzerland 🇨🇭 , Ch

Developed and led registration and post-marketing pharmacokinetic studies.

Switzerland 🇨🇭 , Ch

Characterized chemical compounds for anti-tumor activity in cancer/primary human cell lines.

Mba, Finance & Leadership

Bachelor Of Science Degree, Microbiology